A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy

NYU Langone Health - NYU Dysautonomia Center, New York

Icahn School of Medicine at Mount Sinai, New York

Columbia University, New York

Penn State University - Milton S. Hershey Medical Center, Hershey

The University of Pennsylvania - Pennsylvania Hospital, Philadelphia

Virginia Commonwealth University Medical Center, Richmond

Emory University School of Medicine, Atlanta

Mayo Clinic in Florida, Jacksonville

Norman Fixel Institute for Neurological Diseases - University of Florida, Gainesville

University of Miami Miller School of Medicine, Miami

Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton

Ohio State University, Columbus

Cleveland Clinic, Cleveland

University of Cincinnati College of Medicine, Cincinnati

University of Michigan School of Medicine, Ann Arbor

Quest Research Institute, Farmington Hills

Mayo Clinic - Rochester, Rochester

University of Kansas Medical Center Research Institute, Kansas City

University of Nebraska Medical Center, Omaha

UT Southwestern Medical Center, Dallas

CenExel Rocky Mountain Clinical Research, Englewood

University of Southern California, Los Angeles

David Geffen School of Medicine at UCLA, Los Angeles

The Parkinson's Movement and Disorder Institute, Fountain Valley

Stanford University School of Medicine, Palo Alto

Evergreen Health, Kirkland

Swedish Neuroscience Institute, Movement Disorders Clinic, Seattle

Yale School of Medicine - Yale Church Street Research Unit (CRSU), New Haven

Massachusetts General Hospital, Boston

Brigham and Women's Hospital, Boston

Fujita Health University Hospital, Toyoake

National Hospital Organization Sendai Nishitaga Hospital, Sendai

National Hospital Organization Osaka Toneyama Medical Center, Toyonaka

Tokyo Metropolitan Neurological Hospital, Fuchū

National Hospital Organization Utano National Hospital, Kyoto